-
AGM Voting Result FY21-222021-10-13 07:56:56Read More
-
AGM voting results FY20-212021-10-13 07:54:46Read More
-
AGM Voting results FY19-202021-10-13 07:52:00Read More
-
AGM Voting results FY18-192021-10-13 07:45:32Read More
-
AGM voting results FY17-182021-10-13 07:22:46Read More
-
AGM Voting Results FY16-172021-10-13 06:40:54Read More
-
AGM voting results FY15-162021-10-13 06:35:48Read More
-
AGM Voting results FY14-152021-10-13 06:30:09Read More
-
Notice of Board Meeting for Audited Financial Results and Dividend, if any11.05.2022Read More
-
Newspaper advertisement of extract of unaudited consolidated financial results for Q315.02.2022Read More
-
Intimation of record date for Interim Dividend14.02.2022Read More
-
Declaration of Interim Dividend for FY 2021-2214.02.2022Read More
-
Notice of Board Meeting for Q3 results and Interim Dividend, if any07.02.2022Read More
-
Notice of Board Meeting for Q2 results30.10.2021Read More
-
Related Party Transactions for the half year ended September 30, 2021.30.09.2021Read More
-
Intimation of Record date11.08.2021Read More
-
Grant of Options under Employee Stock Option Scheme11.08.2021Read More
-
Related Party Transactions for the half year ended March 31, 202109.07.2021Read More
-
Newspaper cutting of consolidated financial results for Q4 and year ended March 31, 202115.06.2021Read More
-
Views of the Board of directiors on the reclassification request14.06.2021Read More
-
Recommendation of Final Dividend for FY. 2020-2114.06.2021Read More
-
Recommendation of Final Dividend08.06.2021Read More
-
Notice of Board Meeting04.06.2021Read More
-
Disclosure of receipt of requests from Promoters _ Promoter group memebrs seeking reclassification of status as public27.05.2021Read More
-
Secretarial Compliance Report 31.03.202117.05.2021Read More
-
Launch of new dedicated division Renova to enter Nephrology segment in India06.05.2021Read More
-
Institution of new Employee Stock Option Scheme28.04.2021Read More
-
Outcome of Board meeting01.04.2021Read More
-
Notice of Board meeting25.03.2021Read More
-
Declaration of Interim dividend10.02.2021Read More
-
Board to consider decaration of Interim dividend05.02.2021Read More
-
Notice of Board for Q3 results28.01.2021Read More
-
Related Party transactions for the half year ended 30.09.202026.11.2020Read More
-
Newspaper advertisement of extract of unaudited consolidated financial results for Q211.11.2020Read More
-
Appointment of Chief Executive Officer _ Whole time Director05.10.2020Read More
-
Announcement of appointment of Mr.Nikhil Chopra as CEO _ Whole time director05.10.2020Read More
-
Board Meeting Norice for Q1 results05.09.2020Read More
-
Advertisement for dispatch of Letter of offer05.09.2020Read More
-
Resignation of Independent directors01.09.2020Read More
-
Detailed reasons for Encumbrance31.08.2020Read More
-
Change in Board of Directors31.08.2020Read More
-
Recommendation of IDC under SEBI SAST regulations27.08.2020Read More
-
Related party transctions for the half year eneded March 202018.07.2020Read More
-
Letter of offer13.07.2020Read More
-
Notice of board meeting for annual financial results for the year ended March 31, 202011.07.2020Read More
-
Board to consider recommedation of final dividend11.07.2020Read More
-
Recommendation of Final Dividend for FY 2019-2025.06.2020Read More
-
Secretarial Compliance Report -31.03.202018.06.2020Read More
-
ANDA approval by USFDA27.04.2020Read More
-
News about Ranitidine formulations in the US02.04.2020Read More
-
Intimation of Record Date for interim dividend20.02.2020Read More
-
Declaration of Interim Dividend for FY 2019-2020.02.2020Read More
-
US FDA approval of new Solid Oral Dosage forms formulations manufacturing facility at Panoli, Gujarat11.02.2020Read More
-
Successful US FDA inspection of Solid Oral Dosage forms formulations manufacturing facility at Panoli, Gujarat10.02.2020Read More
-
Board to consider and declare interim dividend05.02.2020Read More
-
Acquistion of Trademarks04.02.2020Read More
-
Notice of board meeting for Q3 results06.01.2020Read More
-
J.B Chemicals clears the confusion about Rantac20.12.2019Read More
-
Regulatory one-time increase in price of Metronidazole formulations16.12.2019Read More
-
Related party transctions for the half year eneded September 201920.11.2019Read More
-
Notice of board meeting for Q2 results04.10.2019Read More
-
Notice of board meeting for Q1 results19.07.2019Read More
-
Intimation of Record Date19.07.2019Read More
-
Related party transctions for the half year eneded March 201906.06.2019Read More
-
Recommedation of dividend for FY 2018-1921.05.2019Read More
-
Board to consider recommedation of dividend08.05.2019Read More
-
Notice of board meeting for audited annual financial results for the year ended March 31, 201905.04.2019Read More
-
Notice of Board Meeting for Q3 results10.01.2019Read More
-
Notice of Board Meeting for Q2 results16.10.2018Read More
-
channge in dividend payment date02.08.2018Read More
-
Notice of Board Meeting for Q125.07.2018Read More
-
Board to consider recommendation of Dividend27.04.2018Read More
-
Notice of board meeting for Q3 results14.01.2018Read More
-
Notice of board meeting for Q2 results27.10.2017Read More
-
Change in dividend payment date27.08.2017Read More
-
Notice of board meeting for Q1 results27.07.2017Read More
-
Recommanadation of dividend for FY 2016-1723.05.2017Read More
-
Notice of board meeting for audited annual financial results for the year ended March 31, 201704.05.2017Read More
-
Board to consider recommandation of Dividend for FY 2016-1704.05.2017Read More
-
Resignation of Director – Dr. Niranjan N. Maniar13.11.2016Read More
-
CSR Commitment13.10.2016Read More
-
Notice of board meeting for Q3 results04.10.2016Read More
-
Notice of board meeting for Q2 results04.10.2016Read More
-
Resignation of a director – Mr. Jashvantrai Joshi29.09.2016Read More
-
Intimation of record date _ book closure date for final dividend FY2015-1616.08.2016Read More
-
Notice of board meeting for Q1 results22.07.2016Read More
-
Notice of Board Meeting for audited annual fiancial results for the year ended March 31, 201620.04.2016Read More
-
Resignation of a director – Mr. Mahesh K. Shroff11.03.2016Read More
-
Declaration of Interim Dividend for FY 2015-1611.03.2016Read More
-
Appointment of Indepenent Director-Mr. Shaukat Merchant16.02.2016Read More
-
Notice of Board Meeting for Q3 results06.01.2016Read More
-
Information under clause 36 of the Listing Agreement04.11.2015Read More
-
Notice of Board Meeting for Q2 results13.10.2015Read More
-
Intimation of change in dividend payment date07.09.2015Read More
-
Intimation of Book Closure07.09.2015Read More
-
Notice of Board Meeting for Q1 results22.07.2015Read More
-
Advance opportunity for registration of email-id31.05.2015Read More
-
Notice of Board Meeting for audited financial results for the year ended March 31, 201507.05.2015Read More
-
Notice of board meeting for Q3 results31.12.2014Read More
-
Appointment of Director – Mr. Devang Shah17.12.2014Read More
-
Resignation of a director-Shri Bansidhar S. Mehta31.10.2014Read More
-
Notice of board meeting for Q2 results21.10.2014Read More
-
Notice of board meeting for Q1 results30.06.2014Read More
-
Recommendaton of dvidend for F.Y.2013-1426.05.2014Read More
-
Intimation to stock exchanges – Scheme of Amalgamation and Arrangement15.03.2014Read More